Stocks Hitting 52-Week Lows

shares touched a new 52-week low of $9.67 after the company provided an update on its Phase 2 ALPINE clinical trial following a pre-planned January 23 interim efficacy assessment of the clinical trial by an independent data safety monitoring board.

shares reached a new 52-week low of $52.07. Macquarie downgraded Packaging Corp Of America from Neutral to Underperform.

shares fell 2.20 percent to touch a new 52-week low of $15.59. Fifth Third Bancorp shares have dropped 11.10 percent over the past 52 weeks, while the S&P 500 index has declined 7.30 percent in the same period.

shares touched a new 52-week low of $14.87. Macquarie downgraded KapStone Paper and Packaging from Neutral to Underperform.